Occult hepatitis B virus infection of donor and recipient origin after liver transplantation despite nucleoside analogue prophylaxis.
Cheung
Cindy Ka Yee
CK
Department of Surgery, University of Hong Kong, Hong Kong, China.
Lo
Chung Mau
CM
Man
Kwan
K
Lau
George Ka Kit
GK
D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use; D004279:DNA, Viral / Q000032:analysis; D005260:Female; D006509:Hepatitis B / Q000276:immunology / Q000517:prevention & control / Q000821:virology; D006512:Hepatitis B Core Antigens / Q000276:immunology; D006514:Hepatitis B Surface Antigens / Q000276:immunology; D006515:Hepatitis B virus / Q000235:genetics / Q000276:immunology; D006801:Humans; D007136:Immunoglobulins / Q000494:pharmacology / Q000627:therapeutic use; D007150:Immunohistochemistry; D019259:Lamivudine / Q000494:pharmacology / Q000627:therapeutic use; D016031:Liver Transplantation / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009705:Nucleosides / Q000494:pharmacology / Q000627:therapeutic use; D014019:Tissue Donors
D000998:Antiviral Agents; D004279:DNA, Viral; D006512:Hepatitis B Core Antigens; D006514:Hepatitis B Surface Antigens; D007136:Immunoglobulins; D009705:Nucleosides; D019259:Lamivudine